Markus Mayer
Company: Alentis
Job title: Vice President of R&D
Seminars:
Discovering the Effect of Anti-Claudin-1 Antibodies in Preclinical Models of Liver Fibrosis & Cancer 2:00 pm
• Deep diving into translational models: ex vivo human (liver spheroids, liver slices), mice with humanized livers, predictive liver signature • Investigating Claudin-1 as a therapeutic target in advanced liver diseaseRead more
day: Day 1 Stream 2 PM